Bio-FD&C Co

Bio-FD&C Co Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Bio-FD&C Co (251120.KQ) as of Nov 14, 2026 is 104.80. In the previous year, Cash Conversion Cycle (CCC) was 187.57 — a change of -44.13% (lower).

Cash Conversion Cycle

104.80

YoY

-44.13%

Last updated:

Cash Conversion Cycle (CCC) of Bio-FD&C Co is 2025 104.80 . Cash Conversion Cycle (CCC) of Bio-FD&C Co was 2024 187.57 . It decreases by -44.13% lower compared to the previous year.

The Bio-FD&C Co Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
153.27 KRW
Jan 1, 2019
158.28 KRW
Jan 1, 2020
197.15 KRW
Jan 1, 2021
84.62 KRW
Jan 1, 2022
164.51 KRW
Jan 1, 2023
180.93 KRW
Jan 1, 2024
187.57 KRW
Jan 1, 2025
104.80 KRW
The Bio-FD&C Co Cash Conversion Cycle history
YEARCash Conversion CycleYoY
104.80-44.13%
187.57+3.67%
180.93+9.98%
164.51+94.42%
84.62-57.08%
197.15+24.56%
158.28+3.26%
153.27—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

Cash Conversion Cycle (CCC) of Bio-FD&C Co is 104.80 in 2025.

Cash Conversion Cycle (CCC) of Bio-FD&C Co changed from 187.57 to 104.80, representing a -44.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Bio-FD&C Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Bio-FD&C Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Bio-FD&C Co